Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
- Sponsor
- University of Bari
- Study ID
- NCT07677631
- Status
- Recruiting
Conditions
- Chronic Pain
- Fibromyalgia
- Nociplastic Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Emotional Allodynia Questionnaire (AEQ) is an 11-item self-report instrument that measures disproportionate emotional reactivity to low-intensity interpersonal cues(perceived unresponsiveness, exclusion, loss of reciprocity), a pattern termed emotional allodynia. It was preliminarily validated in a single-center fibromyalgia sample. PEARL (validation phase) is a multicenter, prospective, observational psychometric validation study that (1) replicates the internal structure and convergent validity of the AEQ in an independent fibromyalgia sample, (2) tests its known-groups (discriminative) accuracy in separating fibromyalgia from non-fibromyalgia chronic pain of defined nociceptive or neuropathic origin, expressed as the area under the ROC curve (AUC), and (3) assesses test-retest reliability. There is no intervention.
Key Dates
- First listed
- Jul 1, 2026
- Start date
- Sep 10, 2025
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 423 participants (estimated)
Arms
- Arm: Fibromyalgia casesAdults with fibromyalgia diagnosed per the 2016 ACR criteria.
- Arm: Non-fibromyalgia chronic pain controlsAdults with chronic non-cancer pain of defined nociceptive or neuropathic origin who do not meet the 2016 ACR criteria for fibromyalgia.
Primary Outcome Measure
Internal consistency of the Emotional Allodynia Questionnaire (AEQ) in fibromyalgia cases [ Time Frame: Baseline (T0) ]
Central Contacts
- Alberto Corriero, MD, PhD+39 3280072443
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory TestingRecruiting · Anna Evans Phillips · Baltimore, Maryland
- Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.PHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona